Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder

被引:15
|
作者
Candido, CL
Romney, DM
机构
[1] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
[2] Hull Child & Family Serv, Calgary, AB T2W 2Z8, Canada
关键词
schizophrenia; depression; paranoid; nonparanoid;
D O I
10.1016/S0165-0327(01)00353-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Depression occurring in schizophrenia is a common problem; however, investigators have typically not studied it with the paranoid/nonparanoid dichotomy in mind. This study examines the quality as well as the severity of depression in three psychiatric groups: paranoid schizophrenia patients, nonparanoid schizophrenia patients, and nonpsychotic major depression patients. Method: Clinical and sociodemographic data were collected on 27 paranoid and 27 nonparanoid schizophrenia patients during their postpsychotic phase while they were at least mildly depressed, and a comparison group of 27 nonpsychotic patients diagnosed with major depressive disorder. The three groups were then assessed on various psychometric scales for severity of depression, profile of symptoms, suicidal risk, and anhedonia. Results: The paranoid schizophrenia patients were more depressed and more at risk for suicide than the nonparanoid schizophrenia patients, yet their depressive profiles and levels of anhedonia were similar. Conclusions: Depressed mood and anhedonia constitute serious problems for schizophrenia patients, but particularly for paranoid schizophrenia patients during the postpsychotic phase of their illnesses. Clinical implications: Schizophrenia patients, especially those with the paranoid features, should be routinely evaluated and monitored for depression. Apart from treatment with drugs, cognitive therapy may be considered a viable option, particularly for paranoid schizophrenia patients. Limitations: Gender was not matched for the two schizophrenia groups and extrapyramidal side effects were not measured. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:261 / 271
页数:11
相关论文
共 50 条
  • [21] Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline
    Mosca, Daniel
    Zhang, Min
    Prieto, Rita
    Boucher, Matthieu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 182 - 192
  • [22] Impaired attention-dependent augmentation of MMN in nonparanoid vs paranoid schizophrenic patients: A comparison with obsessive-compulsive disorder and healthy subjects
    Oades, RD
    DittmannBalcar, A
    Zerbin, D
    Grzella, I
    BIOLOGICAL PSYCHIATRY, 1997, 41 (12) : 1196 - 1210
  • [23] Alexithymia and depression -: A prospective study of patients with major depressive disorder
    Honkalampi, K
    Hintikka, J
    Laukkanen, E
    Lehtonen, J
    Viinamäki, H
    PSYCHOSOMATICS, 2001, 42 (03) : 229 - 234
  • [24] Depression and Major Depressive Disorder in Patients with Parkinson's Disease
    Inoue, Takeshi
    Kitagawa, Mayumi
    Tanaka, Teruaki
    Nakagawa, Shin
    Koyama, Tsukasa
    MOVEMENT DISORDERS, 2010, 25 (01) : 44 - 49
  • [25] DIFFERENCES BETWEEN PARANOID AND NONPARANOID SCHIZOPHRENIC-PATIENTS ON THE SOMATOSENSORY-P300 EVENT-RELATED POTENTIAL
    LOUZA, MR
    MAURER, K
    NEUROPSYCHOBIOLOGY, 1989, 21 (02) : 59 - 66
  • [26] Early onset of depression and treatment outcome in patients with major depressive disorder
    Herzog, David P.
    Wagner, Stefanie
    Engelmann, Jan
    Treccani, Giulia
    Dreimueller, Nadine
    Mueller, Marianne B.
    Tadic, Andre
    Murck, Harald
    Lieb, Klaus
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 139 : 150 - 158
  • [27] EXAMINING THE DIFFERENCES BETWEEN PATIENTS TREATED FOR MAJOR DEPRESSIVE DISORDER COMPARED TO THOSE WHO DO NOT REALIZE THEY HAVE MAJOR DEPRESSIVE DISORDER
    Gross, H. J.
    Vietri, J.
    Chapnick, J.
    VALUE IN HEALTH, 2012, 15 (04) : A90 - A90
  • [28] SELF-CONSCIOUSNESS DISORDERS IN SCHIZOPHRENIC-PATIENTS WITH DEPRESSIVE AND DEPRESSIVE-PARANOID SYNDROMES
    NOSACHEV, GN
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1987, 87 (05): : 709 - 713
  • [29] Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder
    Katzman, Martin A.
    Nierenberg, Andrew A.
    Wajsbrot, Dalia B.
    Meier, Ellen
    Prieto, Rita
    Pappadopulos, Elizabeth
    Mackell, Joan
    Boucher, Matthieu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (05) : 555 - 561
  • [30] Pericardial adipose tissue and the metabolic syndrome is increased in patients with chronic major depressive disorder compared to acute depression and controls
    Kahl, K. G.
    Herrmann, J.
    Stubbs, B.
    Krueger, T. H. C.
    Cordes, J.
    Deuschle, M.
    Schweiger, U.
    Hueper, K.
    Helm, S.
    Birkenstock, A.
    Hartung, D.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 72 : 30 - 35